JP2008509143A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509143A5
JP2008509143A5 JP2007524916A JP2007524916A JP2008509143A5 JP 2008509143 A5 JP2008509143 A5 JP 2008509143A5 JP 2007524916 A JP2007524916 A JP 2007524916A JP 2007524916 A JP2007524916 A JP 2007524916A JP 2008509143 A5 JP2008509143 A5 JP 2008509143A5
Authority
JP
Japan
Prior art keywords
medicament
dispersion
pressure gas
medicament according
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007524916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509143A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/027428 external-priority patent/WO2006017505A2/en
Publication of JP2008509143A publication Critical patent/JP2008509143A/ja
Publication of JP2008509143A5 publication Critical patent/JP2008509143A5/ja
Pending legal-status Critical Current

Links

JP2007524916A 2004-08-04 2005-08-03 気道疾患の処置のためのプレコナリルを含む薬学的処方物 Pending JP2008509143A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59861804P 2004-08-04 2004-08-04
PCT/US2005/027428 WO2006017505A2 (en) 2004-08-04 2005-08-03 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008192563A Division JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Publications (2)

Publication Number Publication Date
JP2008509143A JP2008509143A (ja) 2008-03-27
JP2008509143A5 true JP2008509143A5 (https=) 2008-09-25

Family

ID=35583475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007524916A Pending JP2008509143A (ja) 2004-08-04 2005-08-03 気道疾患の処置のためのプレコナリルを含む薬学的処方物
JP2008192563A Pending JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008192563A Pending JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Country Status (6)

Country Link
US (1) US20060030550A1 (https=)
EP (1) EP1819329A2 (https=)
JP (2) JP2008509143A (https=)
CA (1) CA2575932A1 (https=)
MX (1) MX2007001561A (https=)
WO (1) WO2006017505A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902177B2 (en) * 2005-05-02 2011-03-08 Wandzel Richard A Treatment of congestion using steroids and adrenergics
CA2641616A1 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
US20070202055A1 (en) * 2006-02-09 2007-08-30 Julianne Berry Pharmaceutical Formulations
MX2008010350A (es) * 2006-02-09 2008-10-31 Schering Corp Formulaciones farmaceuticas.
CN1907293B (zh) * 2006-08-22 2012-07-04 蔡海德 一种治疗肺炎的组合药物及其制备方法
US20080069874A1 (en) * 2006-09-15 2008-03-20 Auriga Laboratories, Inc. Kits for Prevention and Treatment of Rhinitis
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
TW201016215A (en) * 2008-07-17 2010-05-01 Schering Corp Compositions and uses of antiviral active pharmaceutical agents
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
HK1218720A1 (zh) 2013-04-30 2017-03-10 欧缇托匹克公司 干粉制剂及使用方法
EP4241771A3 (en) 2013-11-08 2023-11-22 Antivirus Therapeutics Methods and compositions for treating sepsis
MX390453B (es) * 2014-06-25 2025-03-19 Optinose Inc Administracion nasal.
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
CN107669635A (zh) * 2016-09-30 2018-02-09 青岛大学 一种用于治疗呼吸系统疾病的气雾剂及其制备方法
CN107513071B (zh) * 2017-08-30 2019-06-04 新乡医学院 一种多功能鬼臼毒素衍生物及其制备方法和应用
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
KR102681843B1 (ko) 2017-09-22 2024-07-05 벡추라 인코포레이티드 스테아르산마그네슘을 갖는 건조 분말 조성물
CN111166719A (zh) * 2019-12-31 2020-05-19 郑州都灵兽药科技有限公司 一种泰拉霉素肠溶颗粒的制备方法
GB202103803D0 (en) * 2021-03-18 2021-05-05 Queens Univ Of Belfast Anti-viral therapy
CN114177176B (zh) * 2021-12-04 2022-07-12 中国农业科学院兰州兽医研究所 化合物盐酸赛庚啶在制备预防或治疗非洲猪瘟药物中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
DE3106995A1 (de) * 1981-02-25 1982-08-19 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von guajocalglycerinether
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4731447A (en) * 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
US5352707A (en) * 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US5894179A (en) * 1997-12-17 1999-04-13 Emerson Electric Co. Motor with strategically placed connector block
AU7584500A (en) * 1999-09-17 2001-04-17 Smithkline Beecham Corporation Use of csaids in rhinovirus infection
EP1251851A1 (en) * 2000-02-03 2002-10-30 Schering Corporation Treating allergic and inflammatory conditions
CA2418162A1 (en) * 2000-07-18 2002-01-24 Smithkline Beecham Corporation Use of il-8 receptor antagonists in the treatment of virus infections
WO2002009699A2 (en) * 2000-07-28 2002-02-07 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
US7429606B2 (en) * 2001-08-29 2008-09-30 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
US20040029864A1 (en) * 2002-02-04 2004-02-12 Pharmacia Corporation Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
AU2003215246A1 (en) * 2002-02-14 2003-09-04 Viropharma Incorporated Methods of reducing rhinovirus contagion and related compositions
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
WO2004094370A2 (en) * 2002-09-10 2004-11-04 Microbiotix, Inc. Antibacterial pyrazole carboxylic acid hydrazides

Similar Documents

Publication Publication Date Title
JP2008297311A (ja) 気道疾患の処置のためのプレコナリルを含む薬学的処方物
JP2008509143A5 (https=)
JP2009526063A (ja) 医薬製剤
DK2486942T3 (en) COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US20070202050A1 (en) Pharmaceutical Formulations
US20100152147A1 (en) Compositions Comprising Azelastine and Methods of Use Thereof
JP2009526062A (ja) 薬学的処方物
US20040235807A1 (en) Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
KR20010033485A (ko) 하나 이상의 류코트리엔 길항제 및 하나 이상의항히스타민제를 포함하는 호흡 및 피부 질환 치료용 조성물
US20060110449A1 (en) Pharmaceutical composition
CN102803285A (zh) 包含甾体[3，2-c]吡唑衍生物和第二药物活性化合物的药物组合物
CN101883562A (zh) 包含西替利嗪以及非β-2-肾上腺素受体激动剂、β-2-肾上腺素受体激动剂或消炎药的组合物及其用于治疗呼吸疾病的用途
JP2004529108A (ja) Ｒ−サルメテロールおよびプロピオン酸フルチカゾンを含んでなる医薬製剤
HK1159518A (en) Compositions comprising azelastine and methods of use thereof